{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:22:08Z","timestamp":1768422128521,"version":"3.49.0"},"reference-count":148,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>The leading cause of death for people with cystic fibrosis (pwCF) continues to be due to respiratory-related illnesses. Both wound repair and immune cell responses are dysregulated in the CF airways, creating a cycle of unresolved injury and perpetuating inflammation. PwCF are predisposed to colonization and infections with opportunistic bacteria like <jats:italic>Pseudomonas aeruginosa (Pa)<\/jats:italic>, the most common adult pathogen in CF. <jats:italic>Pa<\/jats:italic> possesses key virulence factors that can exacerbate chronic inflammation and lung injury. With the approval of highly effective modulator therapies like elexacaftor\/tezacaftor\/ivacaftor (ETI), pwCF eligible for ETI have seen drastic improvements in lung function and clinical outcomes, including an increased life expectancy. While modulator therapies are improving bronchial epithelial cellular processes in wound repair and some areas of immunity, many of these processes do not reach a non-CF baseline state or have not been thoroughly studied. The effect of modulator therapy on <jats:italic>Pa<\/jats:italic> may lead to a reduction in infection, but in more longitudinal studies, there is not always eradication of <jats:italic>Pa<\/jats:italic>, and colonization and infection frequency can return to pre-modulator levels over time. Finally, in this review we explore the current state of additional treatments for CF lung disease, independent of CFTR genotype, including anti-inflammatories, phage-therapies, and <jats:italic>Pa<\/jats:italic> vaccines.<\/jats:p>","DOI":"10.3389\/fcimb.2025.1566495","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:29:53Z","timestamp":1745818193000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Wound repair and immune function in the Pseudomonas infected CF lung: before and after highly effective modulator therapy"],"prefix":"10.3389","volume":"15","author":[{"given":"Emma Lea","family":"Matthews","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan June","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Prokopczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke I.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriel","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarrod W.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Krick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1164\/rccm.200309-1306OC","article-title":"Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa","volume":"169","author":"Aaron","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jcf.2018.03.010","article-title":"CFTR rescue with VX-809 and VX-770 favors the repair of primary airway epithelial cell cultures from patients with class II mutations in the presence of Pseudomonas aeruginosa exoproducts","volume":"17","author":"Adam","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"B3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13223-023-00760-z","article-title":"Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization","volume":"19","author":"Albon","year":"2023","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"11995","DOI":"10.1038\/s41598-023-38300-9","article-title":"Comparative effects of CFTR modulators on phagocytic, metabolic and inflammatory profiles of CF and nonCF macrophages","volume":"13","author":"Aridgides","year":"2023","journal-title":"Sci. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0051924","DOI":"10.1128\/mbio.00519-24","article-title":"Persistence and evolution of Pseudomonas aeruginosa following initiation of highly effective modulator therapy in cystic fibrosis","volume":"15","author":"Armbruster","year":"2024","journal-title":"mBio"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/ppul.25294","article-title":"Pseudomonas aeruginosa colonization in cystic fibrosis: Impact on neutrophil functions and cytokine secretion capacity","volume":"56","author":"Aslanhan","year":"2021","journal-title":"Pediatr. Pulmonol."},{"key":"B7","volume-title":"A Phase 2b Randomised, Double-blind, Parallel-group Study of Alginate Oligosaccharide (OligoG) Dry Powder Inhalation in Addition to Standard of Care Compared to Placebo in Addition to Standard of Care in Patients with Cystic Fibrosis (CF)","year":"2019"},{"key":"B8","volume-title":"CYstic Fibrosis bacterioPHage Study at Yale (CYPHY): A Single-site, Randomized, Double-blind, Placebo-controlled Study of Bacteriophage Therapy YPT-01 for Pseudomonas Aeruginosa Infections in Adults With Cystic Fibrosis","year":"2020"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.819554","article-title":"CFTR modulators restore acidification of autophago-lysosomes and bacterial clearance in cystic fibrosis macrophages","volume":"12","author":"Badr","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-022-04552-0","article-title":"Human distal airways contain a multipotent secretory cell that can regenerate alveoli","volume":"604","author":"Basil","year":"2022","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"10956","DOI":"10.3390\/ijms231810956","article-title":"The CFTR amplifier nesolicaftor rescues TGF-beta1 inhibition of modulator-corrected F508del CFTR function","volume":"23","author":"Bengtson","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01733","article-title":"Deletion of cftr leads to an excessive neutrophilic response and defective tissue repair in a zebrafish model of sterile inflammation","volume":"11","author":"Bernut","year":"2020","journal-title":"Front. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12890-016-0339-5","article-title":"Cystic fibrosis lung environment and Pseudomonas aeruginosa infection","volume":"16","author":"Bhagirath","year":"2016","journal-title":"BMC Pulm. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.tim.2011.04.005","article-title":"Pseudomonas aeruginosa: all roads lead to resistance","volume":"19","author":"Breidenstein","year":"2011","journal-title":"Trends Microbiol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2023-002049","article-title":"Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapy","volume":"11","author":"Burgel","year":"2024","journal-title":"BMJ Open Respir. Res."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01438","article-title":"Role of cystic fibrosis bronchial epithelium in neutrophil chemotaxis","volume":"11","author":"Cabrini","year":"2020","journal-title":"Front. Immunol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1186\/1755-1536-3-2","article-title":"Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha","volume":"3","author":"C\u00e2mara","year":"2010","journal-title":"Fibrogen. Tissue Repair"},{"key":"B18","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrm2233","article-title":"Cellular senescence: when bad things happen to good cells","volume":"8","author":"Campisi","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3390\/ijms22020557","article-title":"Antipseudomonal and immunomodulatory properties of esc peptides: promising features for treatment of chronic infectious diseases and inflammation","volume":"22","author":"Cappiello","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"18988","DOI":"10.1038\/s41598-019-55426-x","article-title":"Bronchial epithelium repair by Esculentin-1a-derived antimicrobial peptides: involvement of metalloproteinase-9 and interleukin-8, and evaluation of peptides\u2019 immunogenicity","volume":"9","author":"Cappiello","year":"2019","journal-title":"Sci. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1136\/thorax-2022-219943","article-title":"Effect of elexacaftor\/tezacaftor\/ivacaftor on airway and systemic inflammation in cystic fibrosis","volume":"78","author":"Casey","year":"2023","journal-title":"Thorax"},{"key":"B22","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/antiox13030368","article-title":"TNFRSF1B signaling blockade protects airway epithelial cells from oxidative stress","volume":"13","author":"Checa","year":"2024","journal-title":"Antioxid. (Basel)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1128\/IAI.01204-08","article-title":"Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands","volume":"77","author":"Chemani","year":"2009","journal-title":"Infect. Immun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"L756","DOI":"10.1152\/ajplung.00038.2023","article-title":"The synthetic aminoglycoside ELX-02 induces readthrough of G550X-CFTR producing superfunctional protein that can be further enhanced by CFTR modulators","volume":"324","author":"Chen","year":"2023","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00311","article-title":"Targeting cytosolic proliferating cell nuclear antigen in neutrophil-dominated inflammation","volume":"3","author":"Chiara","year":"2012","journal-title":"Front. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1574-695X.1997.tb01043.x","article-title":"LasA, alkaline protease and elastase in clinical strains of Pseudomonas aeruginosa: quantification by immunochemical methods","volume":"18","author":"Coin","year":"1997","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/pathophysiology28010011","article-title":"Pathophysiology of lung disease and wound repair in cystic fibrosis","volume":"28","author":"Conese","year":"2021","journal-title":"Pathophysiology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1513\/pats.200801-010AW","article-title":"Epithelial cell-extracellular matrix interactions and stem cells in airway epithelial regeneration","volume":"5","author":"Coraux","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.bbamcr.2016.02.004","article-title":"Pseudomonas aeruginosa lectin LecB inhibits tissue repair processes by triggering beta-catenin degradation","volume":"1863","author":"Cott","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jcf.2004.06.006","article-title":"Cytokines and inflammatory mediators in cystic fibrosis","volume":"3","author":"Courtney","year":"2004","journal-title":"J. Cyst. Fibros."},{"key":"B31","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3390\/cells10020339","article-title":"Epithelial cells and inflammation in pulmonary wound repair","volume":"10","author":"Croasdell Lucchini","year":"2021","journal-title":"Cells"},{"key":"B32","doi-asserted-by":"publisher","first-page":"L715","DOI":"10.1152\/ajplung.00361.2009","article-title":"Epithelial repair mechanisms in the lung","volume":"298","author":"Crosby","year":"2010","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"B33","unstructured":"CF Foundation\n          FDA Approves Expansion of Modulators for People With Certain Rare Mutations\n          \n          2020"},{"key":"B34","volume-title":"2023 Annual Data Report","year":"2024"},{"key":"B35","unstructured":"U.S. National Library of Medicine: NIH\n          TRIKAFTA- elexacaftor, tezacaftor, and ivacaftor kit\n          \n          2020"},{"key":"B36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/labinvest.3780024","article-title":"Pseudomonas aeruginosa virulence factors delay airway epithelial wound repair by altering the actin cytoskeleton and inducing overactivation of epithelial matrix metalloproteinase-2","volume":"80","author":"de Bentzmann","year":"2000","journal-title":"Lab. Invest."},{"key":"B37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ijid.2023.11.013","article-title":"Use of elexacaftor\/tezacaftor\/ivacaftor leads to changes in detection frequencies of Staphylococcus aureus and Pseudomonas aeruginosa dependent on age and lung function in people with cystic fibrosis","volume":"139","author":"Dittrich","year":"2024","journal-title":"Int. J. Infect. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jcf.2017.01.009","article-title":"Pharmacokinetics and safety of cavosonstat (N91115) in healthy and cystic fibrosis adults homozygous for F508DEL-CFTR","volume":"16","author":"Donaldson","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.174888","article-title":"FGF receptors mediate cellular senescence in the cystic fibrosis airway epithelium","volume":"9","author":"Easter","year":"2024","journal-title":"JCI Insight"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1180826","article-title":"Proliferative activity of antigen-specific CD154+ T cells against bacterial and fungal respiratory pathogens in cystic fibrosis decreases after initiation of highly effective CFTR modulator therapy","volume":"14","author":"Eschenhagen","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"L394","DOI":"10.1152\/ajplung.00091.2012","article-title":"Increased expression of senescence markers in cystic fibrosis airways","volume":"304","author":"Fischer","year":"2013","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"B43","volume-title":"2021 Annual Data Report","year":"2021"},{"key":"B44","doi-asserted-by":"publisher","first-page":"21823","DOI":"10.1074\/jbc.274.31.21823","article-title":"Pseudomonas aeruginosa exoenzyme S disrupts Ras-mediated signal transduction by inhibiting guanine nucleotide exchange factor-catalyzed nucleotide exchange","volume":"274","author":"Ganesan","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jcf.2018.11.015","article-title":"Depletion of BAFF cytokine exacerbates infection in Pseudomonas aeruginosa infected mice","volume":"18","author":"Garic","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"B46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1165\/rcmb.2015-0074OC","article-title":"Alpha-1 antitrypsin mitigates the inhibition of airway epithelial cell repair by neutrophil elastase","volume":"54","author":"Garratt","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1046\/j.1462-5822.2001.00107.x","article-title":"Pseudomonas aeruginosa ExoT inhibits in vitro lung epithelial wound repair","volume":"3","author":"Geiser","year":"2001","journal-title":"Cell Microbiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3390\/ijms21030851","article-title":"Neutrophil adaptations upon recruitment to the lung: new concepts and implications for homeostasis and disease","volume":"21","author":"Giacalone","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"eadg5128","DOI":"10.1126\/sciadv.adg5128","article-title":"CAGE sequencing reveals CFTR-dependent dysregulation of type I IFN signaling in activated cystic fibrosis macrophages","volume":"9","author":"Gillan","year":"2023","journal-title":"Sci. Adv."},{"key":"B50","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.cyto.2018.10.015","article-title":"Inactivation of the interleukin-22 pathway in the airways of cystic fibrosis patients","volume":"113","author":"Guillon","year":"2019","journal-title":"Cytokine"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1002\/ppul.26485","article-title":"Impact of Elexacaftor-Tezacaftor-Ivacaftor on lung disease in cystic fibrosis","volume":"58","author":"Gushue","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1128\/jb.173.17.5290-5297.1991","article-title":"Pseudomonas aeruginosa alkaline protease: evidence for secretion genes and study of secretion mechanism","volume":"173","author":"Guzzo","year":"1991","journal-title":"J. Bacteriol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e01968","DOI":"10.1128\/AAC.01968-17","article-title":"In vitro activity of the siderophore cephalosporin, cefiderocol, against carbapenem-nonsusceptible and multidrug-resistant isolates of gram-negative bacilli collected worldwide in 2014 to 2016","volume":"62","author":"Hackel","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1900716","DOI":"10.1183\/13993003.00716-2019","article-title":"IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease","volume":"57","author":"Hagner","year":"2021","journal-title":"Eur. Respir. J."},{"key":"B55","doi-asserted-by":"publisher","first-page":"7606","DOI":"10.3390\/ijms22147606","article-title":"Anti-inflammatory influences of cystic fibrosis transmembrane conductance regulator drugs on lung inflammation in cystic fibrosis","volume":"22","author":"Harwood","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00005-011-0113-6","article-title":"The cystic fibrosis neutrophil: a specialized yet potentially defective cell","volume":"59","author":"Hayes","year":"2011","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"10935","DOI":"10.1038\/s41598-020-67729-5","article-title":"Altered iron metabolism in cystic fibrosis macrophages: the impact of CFTR modulators and implications for Pseudomonas aeruginosa survival","volume":"10","author":"Hazlett","year":"2020","journal-title":"Sci. Rep."},{"key":"B58","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","article-title":"Hallmarks of cellular senescence","volume":"28","author":"Hernandez-Segura","year":"2018","journal-title":"Trends Cell Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1172\/JCI95148","article-title":"Mechanisms and functions of cellular senescence","volume":"128","author":"Herranz","year":"2018","journal-title":"J. Clin. Invest."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1136\/thx.2006.074641","article-title":"Airway remodelling in children with cystic fibrosis","volume":"62","author":"Hilliard","year":"2007","journal-title":"Thorax"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1164\/rccm.201609-1954OC","article-title":"Restoring cystic fibrosis transmembrane conductance regulator function reduces airway bacteria and inflammation in people with cystic fibrosis and chronic lung infections","volume":"195","author":"Hisert","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"909","DOI":"10.2147\/DDDT.S189847","article-title":"Mechanistic research holds promise for bacterial vaccines and phage therapies for Pseudomonas aeruginosa","volume":"13","author":"Hoggarth","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2301228","DOI":"10.1183\/13993003.01228-2023","article-title":"Diminished airway host innate response in people with cystic fibrosis who experience frequent pulmonary exacerbations","volume":"63","author":"Houston","year":"2024","journal-title":"Eur. Respir. J."},{"key":"B64","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1101\/2023.01.22.23284619","article-title":"Aberrant immune programming in neutrophils in cystic fibrosis","volume":"115","author":"Hu","year":"2024","journal-title":"J Leukoc Biol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13578-019-0292-0","article-title":"Caspase-11, a specific sensor for intracellular lipopolysaccharide recognition, mediates the non-canonical inflammatory pathway of pyroptosis","volume":"9","author":"Huang","year":"2019","journal-title":"Cell Biosci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"11741","DOI":"10.1038\/s41598-023-39005-9","article-title":"Phenotypic and genotypic characteristics of Pseudomonas aeruginosa isolated from cystic fibrosis patients with chronic infections","volume":"13","author":"Iwanska","year":"2023","journal-title":"Sci. Rep."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0304555","article-title":"Anti-inflammatory effects of elexacaftor\/tezacaftor\/ivacaftor in adults with cystic fibrosis heterozygous for F508del","volume":"19","author":"Jarosz-Griffiths","year":"2024","journal-title":"PloS One"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1128\/iai.61.7.2848-2853.1993","article-title":"Mechanisms of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro","volume":"61","author":"Kanthakumar","year":"1993","journal-title":"Infect. Immun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jcf.2021.12.015","article-title":"Neutrophil respiratory burst activity is not exaggerated in cystic fibrosis","volume":"21","author":"Kelk","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"B70","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ymthe.2021.08.007","article-title":"IL-6-elafin genetically modified macrophages as a lung immunotherapeutic strategy against Pseudomonas aeruginosa infections","volume":"30","author":"Kheir","year":"2022","journal-title":"Mol. Ther."},{"key":"B71","doi-asserted-by":"publisher","first-page":"13180","DOI":"10.1073\/pnas.0605669103","article-title":"Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix","volume":"103","author":"Kim","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B72","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1165\/ajrcmb.18.1.2740","article-title":"Stimulation of migration and wound repair of Guinea-pig airway epithelial cells in response to epidermal growth factor","volume":"18","author":"Kim","year":"1998","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1038\/s41467-022-30668-y","article-title":"Gene-specific nonsense-mediated mRNA decay targeting for cystic fibrosis therapy","volume":"13","author":"Kim","year":"2022","journal-title":"Nat. Commun."},{"key":"B74","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3390\/biom14040487","article-title":"In silico analysis of the ga(3+)\/fe(3+) competition for binding the iron-scavenging siderophores of P. aeruginosa-implementation of three gallium-based complexes in the \u201cTrojan horse\u201d Antibacterial strategy","volume":"14","author":"Kircheva","year":"2024","journal-title":"Biomolecules"},{"key":"B75","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1038\/s41467-023-39370-z","article-title":"Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa","volume":"14","author":"Kohler","year":"2023","journal-title":"Nat. Commun."},{"key":"B76","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1136\/thx.49.5.496","article-title":"Eosinophilic activation in cystic fibrosis","volume":"49","author":"Koller","year":"1994","journal-title":"Thorax"},{"key":"B77","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nm.3642","article-title":"Lung regeneration: mechanisms, applications and emerging stem cell populations","volume":"20","author":"Kotton","year":"2014","journal-title":"Nat. Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.1007\/s00253-014-5904-3","article-title":"A new assay for rhamnolipid detection-important virulence factors of Pseudomonas aeruginosa","volume":"98","author":"Laabei","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.3390\/jpm12101577","article-title":"Elexacaftor\/tezacaftor\/ivacaftor accelerates wound repair in cystic fibrosis airway epithelium","volume":"12","author":"Laselva","year":"2022","journal-title":"J. Pers. Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/jac\/dkw143","article-title":"Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells","volume":"71","author":"Lashua","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B81","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/imcb.12547","article-title":"Pseudomonas aeruginosa modulates neutrophil granule exocytosis in an in vitro model of airway infection","volume":"100","author":"Laucirica","year":"2022","journal-title":"Immunol. Cell Biol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s15010-019-01319-0","article-title":"Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient","volume":"47","author":"Law","year":"2019","journal-title":"Infection"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e536","DOI":"10.1093\/infdis\/jiae051","article-title":"Impact of CFTR modulation on Pseudomonas aeruginosa infection in people with cystic fibrosis","volume":"230","author":"Ledger","year":"2024","journal-title":"J. Infect. Dis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1083\/jcb.146.2.517","article-title":"Airway epithelial cell migration dynamics. MMP-9 role in cell-extracellular matrix remodeling","volume":"146","author":"Legrand","year":"1999","journal-title":"J. Cell Biol."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.125937","article-title":"FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis","volume":"5","author":"Leslie","year":"2020","journal-title":"JCI Insight"},{"key":"B86","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jcf.2023.04.012","article-title":"The combination elexacaftor\/tezacaftor\/ivacaftor (ETI) modulates the de novo synthethic pathway of ceramides in a genotype-independent manner","volume":"22","author":"Liessi","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1088494","article-title":"Pulmonary bacteriophage and cystic fibrosis airway mucus: friends or foes","volume":"10","author":"Ling","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"key":"B88","doi-asserted-by":"publisher","first-page":"L28","DOI":"10.1152\/ajplung.1999.276.1.L28","article-title":"Neutrophil elastase and elastase-rich cystic fibrosis sputum degranulate human eosinophils in vitro","volume":"276","author":"Liu","year":"1999","journal-title":"Am. J. Physiol."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01662","article-title":"CFTR modulators: the changing face of cystic fibrosis in the era of precision medicine","volume":"10","author":"Lopes-Pacheco","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"054","DOI":"10.1093\/femsre\/fuaa054","article-title":"Vaccines for multidrug resistant Gram negative bacteria: lessons from the past for guiding future success","volume":"45","author":"Lopez-Siles","year":"2021","journal-title":"FEMS Microbiol. Rev."},{"key":"B91","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3390\/antibiotics11050579","article-title":"New drugs for the treatment of Pseudomonas aeruginosa infections with limited treatment options: A narrative review","volume":"11","author":"Losito","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"B92","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jcf.2024.07.012","article-title":"The clinical effectiveness of elexacaftor\/tezacaftor\/ivacaftor (ETI) for people with CF without a F508del variant: A systematic review and meta-analysis","volume":"23","author":"Lupas","year":"2024","journal-title":"J. Cystic Fibros."},{"key":"B93","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1128\/CMR.15.2.194-222.2002","article-title":"Lung infections associated with cystic fibrosis","volume":"15","author":"Lyczak","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"B94","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1128\/iai.62.2.596-605.1994","article-title":"Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis","volume":"62","author":"Mahenthiralingam","year":"1994","journal-title":"Infect. Immun."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100239","article-title":"Transcriptional firing represses bactericidal activity in cystic fibrosis airway neutrophils","volume":"2","author":"Margaroli","year":"2021","journal-title":"Cell Rep. Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13223-023-00822-2","article-title":"The impact of CFTR modulator triple therapy on type 2 inflammatory response in patients with cystic fibrosis","volume":"19","author":"Mehta","year":"2023","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlab188","article-title":"Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections","volume":"3","author":"Meschiari","year":"2021","journal-title":"JAC Antimicrob. Resist."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1513\/AnnalsATS.201404-166OC","article-title":"Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection","volume":"11","author":"Mogayzel","year":"2014","journal-title":"Ann. Am. Thorac. Soc."},{"key":"B99","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.1128\/JB.01651-09","article-title":"Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis","volume":"192","author":"Mulcahy","year":"2010","journal-title":"J. Bacteriol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.freeradbiomed.2006.09.004","article-title":"Premature cellular senescence induced by pyocyanin, a redox-active Pseudomonas aeruginosa toxin","volume":"41","author":"Muller","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1172\/JCI115738","article-title":"Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line","volume":"89","author":"Nakamura","year":"1992","journal-title":"J. Clin. Invest."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095892","article-title":"The B lymphocyte differentiation factor (BAFF) is expressed in the airways of children with CF and in lungs of mice infected with Pseudomonas aeruginosa","volume":"9","author":"Neill","year":"2014","journal-title":"PloS One"},{"key":"B103","doi-asserted-by":"publisher","first-page":"L1077","DOI":"10.1152\/ajplung.00198.2003","article-title":"The Pseudomonas secretory product pyocyanin inhibits catalase activity in human lung epithelial cells","volume":"285","author":"O\u2019Malley","year":"2003","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"L1354","DOI":"10.1152\/ajplung.00054.2015","article-title":"High-mobility group box 1 promotes extracellular matrix synthesis and wound repair in human bronchial epithelial cells","volume":"309","author":"Ojo","year":"2015","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111797","article-title":"Recruited monocytes\/macrophages drive pulmonary neutrophilic inflammation and irreversible lung tissue remodeling in cystic fibrosis","volume":"41","author":"Oz","year":"2022","journal-title":"Cell Rep."},{"key":"B106","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.4049\/jimmunol.169.8.4604","article-title":"The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin","volume":"169","author":"Phipps","year":"2002","journal-title":"J. Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12931-019-1103-1","article-title":"CFTR regulates B cell activation and lymphoid follicle development","volume":"20","author":"Polverino","year":"2019","journal-title":"Respir. Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41522-018-0056-3","article-title":"Targeted disruption of the extracellular polymeric network of Pseudomonas aeruginosa biofilms by alginate oligosaccharides","volume":"4","author":"Powell","year":"2018","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B109","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1365-2958.2005.04552.x","article-title":"Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis","volume":"56","author":"Ramsey","year":"2005","journal-title":"Mol. Microbiol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1165\/ajrcmb\/8.1.63","article-title":"Migration of bovine bronchial epithelial cells to extracellular matrix components","volume":"8","author":"Rickard","year":"1993","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/00063198-200311000-00008","article-title":"Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management","volume":"9","author":"Rosenfeld","year":"2003","journal-title":"Curr. Opin. Pulm. Med."},{"key":"B112","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jcf.2023.04.008","article-title":"Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1\/2 clinical study","volume":"22","author":"Rowe","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"B113","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1096\/fj.201500166R","article-title":"Quorum-sensing inhibition abrogates the deleterious impact of Pseudomonas aeruginosa on airway epithelial repair","volume":"30","author":"Ruffin","year":"2016","journal-title":"FASEB J."},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00182","article-title":"Repair process impairment by Pseudomonas aeruginosa in epithelial tissues: major features and potential therapeutic avenues","volume":"9","author":"Ruffin","year":"2019","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2021.787128","article-title":"Airway basal cells, protectors of epithelial walls in health and respiratory diseases","volume":"2","author":"Ruysseveldt","year":"2021","journal-title":"Front. Allergy"},{"key":"B116","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.3390\/cells9122617","article-title":"Understanding Pseudomonas aeruginosa-host interactions: the ongoing quest for an efficacious vaccine","volume":"9","author":"Sainz-Mejias","year":"2020","journal-title":"Cells"},{"key":"B117","doi-asserted-by":"publisher","first-page":"L164","DOI":"10.1152\/ajplung.00253.2023","article-title":"Extracellular vesicles secreted by primary human bronchial epithelial cells reduce Pseudomonas aeruginosa burden and inflammation in cystic fibrosis mouse lung","volume":"326","author":"Sarkar","year":"2024","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1180282","article-title":"Multimodal analysis of granulocytes, monocytes, and platelets in patients with cystic fibrosis before and after Elexacaftor-Tezacaftor-Ivacaftor treatment","volume":"14","author":"Schmidt","year":"2023","journal-title":"Front. Immunol."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.1663","article-title":"LPS- or Pseudomonas aeruginosa-mediated activation of the macrophage TLR4 signaling cascade depends on membrane lipid composition","volume":"4","author":"Schoeniger","year":"2016","journal-title":"PeerJ"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150109","article-title":"Chemotaxis and binding of Pseudomonas aeruginosa to scratch-wounded human cystic fibrosis airway epithelial cells","volume":"11","author":"Schwarzer","year":"2016","journal-title":"PloS One"},{"key":"B121","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1038\/s41467-021-24575-x","article-title":"A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion","volume":"12","author":"Sharma","year":"2021","journal-title":"Nat. Commun."},{"key":"B122","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1128\/IAI.72.12.6969-6977.2004","article-title":"Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung","volume":"72","author":"Shaver","year":"2004","journal-title":"Infect. Immun."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"B124","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/s1526-0542(03)00028-9","article-title":"Growth factors in cystic fibrosis - when more is not enough","volume":"4","author":"Shute","year":"2003","journal-title":"Paediatr. Respir. Rev."},{"key":"B125","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jaci.2023.06.005","article-title":"Eosinophils and tissue remodeling: Relevance to airway disease","volume":"152","author":"Siddiqui","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1202009","article-title":"Airway macrophages display decreased expression of receptors mediating and regulating scavenging in early cystic fibrosis lung disease","volume":"14","author":"Slimmen","year":"2023","journal-title":"Front. Immunol."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001021.pub4","article-title":"Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis","volume":"11","author":"Smith","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"B128","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.amjms.2024.02.001","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on respiratory colonization in an adult cystic fibrosis clinic","volume":"367","author":"Szabo","year":"2024","journal-title":"Am. J. Med. Sci."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1186\/s13063-022-07047-5","article-title":"Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b\/2, multicenter, randomized, double-blind, placebo-controlled trial","volume":"23","author":"Tamma","year":"2022","journal-title":"Trials"},{"key":"B130","doi-asserted-by":"publisher","first-page":"e03260","DOI":"10.1128\/mBio.03260-19","article-title":"The Pseudomonas aeruginosa lectin lecB causes integrin internalization and inhibits epithelial wound healing","volume":"11","author":"Thuenauer","year":"2020","journal-title":"mBio"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1183\/09031936.94.07101746","article-title":"Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro","volume":"7","author":"Tsang","year":"1994","journal-title":"Eur. Respir. J."},{"key":"B132","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1136\/thoraxjnl-2019-214027","article-title":"Increased extracellular vesicles mediate inflammatory signalling in cystic fibrosis","volume":"75","author":"Useckaite","year":"2020","journal-title":"Thorax"},{"key":"B133","first-page":"443","article-title":"Distribution of epidermal growth factor receptor and ligands during bronchiolar epithelial repair from naphthalene-induced Clara cell injury in the mouse","volume":"151","author":"Van Winkle","year":"1997","journal-title":"Am. J. Pathol."},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.619442","article-title":"CFTR Correctors and Antioxidants Partially Normalize Lipid Imbalance but not Abnormal Basal Inflammatory Cytokine Profile in CF Bronchial Epithelial Cells","volume":"12","author":"Veltman","year":"2021","journal-title":"Front. Physiol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ymthe.2004.06.215","article-title":"Effects of CFTR, interleukin-10, and Pseudomonas aeruginosa on gene expression profiles in a CF bronchial epithelial cell Line","volume":"10","author":"Virella-Lowell","year":"2004","journal-title":"Mol. Ther."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3390\/pharmaceutics15041277","article-title":"Electrosprayed mesenchymal stromal cell extracellular matrix nanoparticles accelerate cellular wound healing and reduce gram-negative bacterial growth","volume":"15","author":"Wandling","year":"2023","journal-title":"Pharmaceutics"},{"key":"B137","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1164\/rccm.202305-0818OC","article-title":"Inflammatory activity of epithelial stem cell variants from cystic fibrosis lungs is not resolved by CFTR modulators","volume":"208","author":"Wang","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1242381","article-title":"Loss of CFTR function in macrophages alters the cell transcriptional program and delays lung resolution of inflammation","volume":"14","author":"Wellems","year":"2023","journal-title":"Front. Immunol."},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1107437","article-title":"Regulatory T cell enhancement in adults with cystic fibrosis receiving Elexacaftor\/Tezacaftor\/Ivacaftor therapy","volume":"14","author":"Westholter","year":"2023","journal-title":"Front. Immunol."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00773","article-title":"Senescence in wound repair: emerging strategies to target chronic healing wounds","volume":"8","author":"Wilkinson","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"B142","doi-asserted-by":"publisher","first-page":"e00115","DOI":"10.1128\/CMR.00115-20","article-title":"New beta-lactam-beta-lactamase inhibitor combinations","volume":"34","author":"Yahav","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jcf.2022.03.009","article-title":"Association between elevated peripheral blood eosinophil count and respiratory outcomes in adults with cystic fibrosis","volume":"21","author":"Ye","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1164\/rccm.202102-0509OC","article-title":"A Phase 3 Open-Label Study of Elexacaftor\/Tezacaftor\/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele","volume":"203","author":"Zemanick","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B145","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/SHK.0000000000001691","article-title":"Direct airway instillation of neutrophils overcomes chemotactic deficits induced by injury","volume":"56","author":"Zhang","year":"2021","journal-title":"Shock"},{"key":"B146","doi-asserted-by":"publisher","first-page":"2102861","DOI":"10.1183\/13993003.02861-2021","article-title":"Cystic fibrosis macrophage function and clinical outcomes after elexacaftor\/tezacaftor\/ivacaftor","volume":"61","author":"Zhang","year":"2023","journal-title":"Eur. Respir. J."},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.03256-23","article-title":"PQS and pyochelin in Pseudomonas aeruginosa share inner membrane transporters to mediate iron uptake","volume":"12","author":"Zhang","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"B148","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1128\/IAI.01772-05","article-title":"Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosa","volume":"74","author":"Zulianello","year":"2006","journal-title":"Infect. Immun."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1566495\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:29:56Z","timestamp":1745818196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1566495\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":148,"alternative-id":["10.3389\/fcimb.2025.1566495"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1566495","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"article-number":"1566495"}}